China Resources Pharmaceutical Group Limited (the “Company”) has published a notice announcing its 2026 first extraordinary general meeting (EGM). The meeting is scheduled for Friday, 6 February 2026, at 10:00 a.m., to be held at Room 201, No.7, Courtyard 2, Middle of North Third Ring Road, Chaoyang District, Beijing, PRC.

The EGM will consider and vote on two proposals. The first is an ordinary resolution to approve and ratify the Sales Framework Agreement 2026/2028, along with its associated terms, transactions, and Annual Caps. The second is a special resolution proposing the approval and adoption of new Articles of Association, with immediate effect upon the close of the meeting.

Procedurally, the register of members will be closed from Tuesday, 3 February 2026 to Friday, 6 February 2026 (inclusive). Shareholders listed on the Company’s register by Friday, 6 February 2026 will be entitled to attend and vote. Proxy forms must be lodged with the registered office at 41st Floor, China Resources Building, 26 Harbour Road, Wanchai, Hong Kong, no less than 48 hours before the start of the EGM. Any vote at the EGM will be conducted by poll, and the results will be published on the Company’s and the Hong Kong Stock Exchange’s websites according to listing requirements.